| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005682 | Clinical Therapeutics | 2005 | 11 Pages |
Abstract
In this short-term study in a selected, small study population with SAC, ketotifen and olopatadine diminished the expression of CAMs and inflammatory markers on the conjunctival surface cells effectively. Both active treatments were more efficacious compared with ATS and were well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
MD Avunduk, PhD Tekelioglu, MD Turk, MD Akyol,